ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 709,75
0,98%
Dow Jones
43 611,07
1,06%
DAX
20 903,39
1,31%
Brent Oil
80,285
-0,29%
Bitcoin
104 815,98
4,81%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Oric Pharmaceuticals Inc (ORIC) Cours

Oric Pharmaceuticals Inc

Oric Pharmaceuticals Inc (ORIC)

NASDAQ
9,69
-0,35
( -3,49% )
Mis à jour : 17:35:25
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
9,69
Prix Achat
9,68
Prix Vente
9,73
Volume échangé
78 094
9,63 Fourchette du Jour 10,20
6,33 Plage de 52 semaines 16,65
Cap du marché
683,794M
Clôture Veille
10,04
Ouverture
10,20
Dernière Transaction
1
@
9.6673
Dernière heure de transaction
17:35:50
Volume financier
US$ 778 890
VWAP
9,9737
Volume moyen (3 m)
468 931
Actions en circulation
70 566 950
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,81
Bénéfice par action (BPA)
-1,43
Chiffre d'affairess
-
Bénéfice net
-100,7M

À propos de Oric Pharmaceuticals Inc

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.oricpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Oric Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ORIC. Le dernier cours de clôture d'Oric Pharmaceuticals était de US$10,04. Au cours de la dernière année, les actions de Oric Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 6,33 à US$ 16,65.

Oric Pharmaceuticals compte actuellement 70 566 950 actions en circulation. La capitalisation boursière d'Oric Pharmaceuticals est de US$708,49 million. Oric Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -6.81.

ORIC Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones

Announces encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with apalutamide in patients with mCRPC Entered into clinical trial collaboration...

13 Janvier 2025
GlobeNewswire Inc.

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

13 Janvier 2025
GlobeNewswire Inc.

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

06 Janvier 2025
GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

03 Janvier 2025
GlobeNewswire Inc.

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...

25 Novembre 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

Presented preclinical data further supporting the potential best-in-class profile of ORIC-114 to treat EGFR exon 20 insertions and other atypical mutations at the EORTC-NCI-AACR Conference...

12 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.5919.62962962968.111.157.868662009.74038356CS
42.13528.25943084057.55511.157.446259339.06484274CS
121.2514.81042654038.4411.157.414689319.15596787CS
26-1.52-13.559322033911.2112.837.414587999.61551936CS
521.3716.46634615388.3216.656.3351612910.13704912CS
156-3.02-23.760818253312.7116.652.364544397.43341318CS
260-16.31-62.73076923082640.812.3637118211.45181416CS

ORIC - Frequently Asked Questions (FAQ)

What is the current Oric Pharmaceuticals share price?
The current share price of Oric Pharmaceuticals is US$ 9,69
How many Oric Pharmaceuticals shares are in issue?
Oric Pharmaceuticals has 70 566 950 shares in issue
What is the market cap of Oric Pharmaceuticals?
The market capitalisation of Oric Pharmaceuticals is USD 708,49M
What is the 1 year trading range for Oric Pharmaceuticals share price?
Oric Pharmaceuticals has traded in the range of US$ 6,33 to US$ 16,65 during the past year
What is the PE ratio of Oric Pharmaceuticals?
The price to earnings ratio of Oric Pharmaceuticals is -6,81
What is the reporting currency for Oric Pharmaceuticals?
Oric Pharmaceuticals reports financial results in USD
What is the latest annual profit for Oric Pharmaceuticals?
The latest annual profit of Oric Pharmaceuticals is USD -100,7M
What is the registered address of Oric Pharmaceuticals?
The registered address for Oric Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Oric Pharmaceuticals website address?
The website address for Oric Pharmaceuticals is www.oricpharma.com
Which industry sector does Oric Pharmaceuticals operate in?
Oric Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BDMDBaird Medical Investment Holdings Ltd
US$ 11,26
(107,75%)
6,82M
NUKKNukkleus Inc
US$ 32,1953
(56,82%)
15,51M
GSITGSI Technology
US$ 4,04
(46,91%)
62,38M
VSVersus Systems Inc
US$ 2,7801
(44,80%)
59,81M
BZAIBlaize Holdings Inc
US$ 9,00
(38,46%)
1,79M
BLRXBioLineRx Ltd
US$ 0,0977
(-19,85%)
18,82M
SHOTWSafety Shot Inc
US$ 0,1855
(-17,56%)
3,36k
PCLAPicoCELA Inc
US$ 2,43
(-14,44%)
60,98k
VRMEVerifyMe Inc
US$ 3,7012
(-13,93%)
1,53M
PTLEPTL Ltd
US$ 2,82
(-13,23%)
937,86k
GCTKGlucoTrack Inc
US$ 0,0983
(33,20%)
310,84M
TGLTreasure Global Inc
US$ 0,2768
(29,16%)
243,17M
RIMEAlgorhythm Holdings Inc
US$ 0,0396
(-6,38%)
173,83M
CRKNCrown Electrokinetics Corporation
US$ 0,1004
(25,97%)
100,8M
NVDANVIDIA Corporation
US$ 138,01
(3,32%)
94,14M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés